![]() |
![]() |
||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
| ER Quality Control Mechanism and ERAD | |||||||||||||||||||||||||||||||||||||||||||||
| Most of the secretory proteins and membrane proteins are synthesized in the ER (endoplasmic reticulum). ER has a quality control mechanism which discriminates correctly folded proteins from immature or misfolded ones, and retains the latter in the ER (Fig. 1).1,2 Protein folding and oligomer formation are assisted by a group of ER resident proteins known as ER chaperone proteins, and only correctly folded proteins are transported out of the ER to the Golgi apparatus. The folding mechanisms of newly synthesized proteins in the ER are similar to those in the cytoplasm, but ER is different in that the redox potential is biased to oxidization and that most of the proteins synthesized in the ER are cotranslationally modified with N (asparagine)-linked glycans. | |||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Fig. 1 Scheme of ER quality control and ERAD (modified from Ref. 5) | |||||||||||||||||||||||||||||||||||||||||||||
| The ER proteins misfold and sometimes aggregate when cells are exposed to ER stress by the addition of reducing reagents or an inhibitor of glycosylation to cells. Proteins misfold terminally because of premature termination of the protein or by the mutation of even one amino acid residue, such phenomena are observed in some genetic diseases. It has also been reported recently that all the newly synthesized proteins misfold stochastically in part during folding process. ER chaperone proteins such as GRP78/BiP (glucose-regulated protein 78/Immunoglobulin heavy chain binding protein) bind to these misfolded proteins in the ER to prevent aggregation, and support them to refold correctly. Terminally misfolded proteins are destined for intracellular degradation to prevent secretion or transport to its final destinations. Recently, it has been clarified that these misfolded proteins in the ER are degraded by the cytoplasmic proteasome after they are retrotranslocated out of the ER, and this mechanism is known as ERAD (ER-associated degradation) (Fig. 1).3,4 It is now known that not only misfolded proteins but normal proteins can also become the substrate for ERAD. For example, down-regulation of enzymes involved in fatty acid or cholesterol synthesis is mediated by ERAD. | |||||||||||||||||||||||||||||||||||||||||||||
| ERAD of Glycoproteins | |||||||||||||||||||||||||||||||||||||||||||||
|
Many of the proteins synthesized in the ER have asparagine-linked Glc3Man9GlcNAc2
glycan added to its consensus sites. In the ER, several enzymes remove
and add sugars to the oligosaccharides (Fig. 2A).1,
2 Although glycans attached to each glycoprotein are
diverse after maturation, the glycan modifications in the ER are uniform.
This suggests that the quality control of various glycoproteins in the
ER is mediated by a common mechanism through the recognition of the
glycan moiety attached to them. Lectin-like molecular chaperones calnexin
and calreticulin recognize the Glc1Man9GlcNAc2
oligosaccharide and assist the folding of newly synthesized glycoproteins.
Next, the mannose residue from the middle branch of the Man9GlcNAc2
oligosaccharide is removed by ER |
|||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Fig. 2 Structure of N-linked oligosaccharide and its trimming in the ER | |||||||||||||||||||||||||||||||||||||||||||||
| The mannose trimming of N-linked glycan also plays an important role in the ERAD of glycoproteins (Fig. 1). In both yeast and human cells, it is reported that the misfolded glycoproteins in the ER are degraded through ERAD only after the glycan is trimmed to the Man8B form, while misfolded proteins stay within the ER when they have the Man9 form of oligosaccharides. Accordingly, it is assumed that there exists a Man8-binding lectin which recognizes misfolded glycoproteins in the Man8B form in the ER and sort them to the ERAD pathway.4 | |||||||||||||||||||||||||||||||||||||||||||||
| Molecular Cloning of Mouse EDEM | |||||||||||||||||||||||||||||||||||||||||||||
|
When ER stress is subjected to cells, misfolded proteins accumulate
in the ER, which then induces the UPR (unfolded protein response) to
cells.6 Consequently,
the synthesis of ER chaperone proteins as well as molecules involved
in ERAD is upregulated to circumvent the adverse condition.7,8
We have cloned a novel mouse gene which is induced by ER stress using
a PCR-based subtraction method.9
This encodes a type II transmembrane protein in the ER consisting of
652 amino acids, and has partial homology with processing |
|||||||||||||||||||||||||||||||||||||||||||||
| EDEM Is Similar
to |
|||||||||||||||||||||||||||||||||||||||||||||
|
EDEM protein is 18 % identical with human ER |
|||||||||||||||||||||||||||||||||||||||||||||
| EDEM Accelerates ERAD of Glycoproteins | |||||||||||||||||||||||||||||||||||||||||||||
|
We next examined whether EDEM is involved in the ERAD. We used |
|||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Fig. 3
EDEM accelerates the ERAD of misfolded
|
|||||||||||||||||||||||||||||||||||||||||||||
|
EDEM gene is evolutionally conserved and the yeast Saccharomyces cerevisiae has a homologue. It has been reported that the Mnl1p/Htm1p gene, the yeast homologue of mouse EDEM, also accelerates the ERAD of misfolded glycoproteins.11,12 Our working hypothesis on the function of EDEM is schematically shown in Fig. 4. We are now trying to clarify the mechanism of how EDEM works on the recognition and sorting of the misfolded glycoproteins. |
|||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Fig. 4 Scheme of the function of EDEM | |||||||||||||||||||||||||||||||||||||||||||||
| ER Stress, UPR and ERAD | |||||||||||||||||||||||||||||||||||||||||||||
|
As described above, the expression of EDEM is upregulated by ER stress. This is not specific to EDEM, and many of the molecules involved in ERAD are reported to be induced by ER stress.7 ER is an intracellular compartment with high calcium concentration
in which proteins are oxidized and modified with N-linked oligosaccharides.
ER stress is a condition which accumulates misfolded or unfolded proteins
by disturbing these ER circumstances. To circumvent this adverse condition,
cells and organisms respond to the ER stress by evoking several adaptation
mechanisms.13 First is
the transcriptional upregulation of ER chaperone proteins to prevent
the unfolded proteins from aggregation and to promote refolding. This
signaling pathway from the ER to the nucleus is known as UPR.6
Second, cells attenutate the protein synthesis by phosphorylating eIF-2 ERAD system is now clarified to be involved in various cellular mechanisms, and further research is under way in relation to various protein-folding diseases and ER stress. |
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
| Aug. 5, 2002 / Copyright (c) Glycoforum, All Rights Reserved. |
|
|